×

Concerned about your own or
someone else’s drug use?

The National Alcohol and Other Drug Hotline

For free and confidential advice about alcohol and other drugs, call the National Alcohol and Other Drug hotline: 1800 250 015. It will automatically direct you to the Alcohol and Drug Information Service in your state or territory. Click here for more information

Counselling online

An online text-based counselling for people concerned about their own drinking or drug use. The service is equally available to people concerned about a family member, relative or friend. Click here for more information

Cracks in the ice

An online toolkit providing evidence-based and up-to-date information and resources about crystal methamphetamine (ice) for the Australian community. Click here for more information

Generate

New evidence
based knowledge

NCCRED Clinical Research Funding

Allocated and available funding

Jump down to

Funding recipients

Seed Funding Recipients: Round 4

A key objective of NCCRED is to provide seed-funding to establish new clinical trials and clinical research, in order to build capacity for clinical research in the Alcohol and Other Drug (AOD) sector. In the fourth funding round, value-add projects were also considered with the aim to add value to current projects which related to methamphetamine or emerging drugs of concern.  Projects were awarded through a formal application process with the level of funding determined by the NCCRED Board.

Cannabidiol – A novel pharmacotherapy for Lowering Methamphetamine use (The CALM Study)

Principal Investigator: Dr Gill Bedi, Orygen National, University of Melbourne.

Amount Awarded: $99,408.00

Cannabidiol – A novel pharmacotherapy for Lowering Methamphetamine use (The CALM Study)

Principal Investigator: Dr Gill Bedi, Orygen National, University of Melbourne.

Amount Awarded: $99,408.00

Feasibility and preliminary efficacy of Cognitive Remediation Groups in a community outpatient setting for people who use methamphetamines.

Principal Investigator: A/Prof Peter Kelly, University of Wollongong.

Amount Awarded: $74,738.00

Feasibility and preliminary efficacy of Cognitive Remediation Groups in a community outpatient setting for people who use methamphetamines.

Principal Investigator: A/Prof Peter Kelly, University of Wollongong.

Amount Awarded: $74,738.00

Theta burst Transcranial Magnetic Stimulation (TMS) for Methamphetamine use disorder– A feasibility study to inform the design of a multisite randomised control trial.

Principal Investigator: Dr Buddhima Lokuge & Dr. Tarun Yadav, Hunter New England Local Health District

Amount Awarded: $100,000.00

Theta burst Transcranial Magnetic Stimulation (TMS) for Methamphetamine use disorder– A feasibility study to inform the design of a multisite randomised control trial.

Principal Investigator: Dr Buddhima Lokuge & Dr. Tarun Yadav, Hunter New England Local Health District

Amount Awarded: $100,000.00

Integrating contingency management for methamphetamine use into routine clinical care in Australia

Principal Investigator: A/Prof Rebecca McKetin, University of New South Wales.

Amount Awarded: $86,109.00

Integrating contingency management for methamphetamine use into routine clinical care in Australia

Principal Investigator: A/Prof Rebecca McKetin, University of New South Wales.

Amount Awarded: $86,109.00

Examining the effects of Amphetamine-Type-Substance use on clinical outcomes among clients receiving opioid agonist treatment

Principal Investigator: Dr Llewellyn Mills, South Eastern Local Health District.

Amount Awarded: $42,536.78

Examining the effects of Amphetamine-Type-Substance use on clinical outcomes among clients receiving opioid agonist treatment

Principal Investigator: Dr Llewellyn Mills, South Eastern Local Health District.

Amount Awarded: $42,536.78

Co-designing a fixed-site drug checking service at Sydney’s Medically Supervised Injecting Centre (MSIC)

Principal Investigator: Dr Robert Page, The Loop Australia / University of New South Wales

Amount Awarded: $57,159.00

Co-designing a fixed-site drug checking service at Sydney’s Medically Supervised Injecting Centre (MSIC)

Principal Investigator: Dr Robert Page, The Loop Australia / University of New South Wales

Amount Awarded: $57,159.00

Seed Funding Recipients: Round 3

An open label pilot study of intranasal oxytocin for methamphetamine withdrawal in women

Principal Investigator: Dr Shalini Arunogiri, Turning Point, Eastern Health

Amount awarded: $97,844.25

An open label pilot study of intranasal oxytocin for methamphetamine withdrawal in women

Principal Investigator: Dr Shalini Arunogiri, Turning Point, Eastern Health

Amount awarded: $97,844.25

Co-design of clinical alerts as part of a drug early warning network in Victoria, Australia

Principal Investigator: Dr Monica Barratt, Royal Melbourne Institute of Technology.

Amount Awarded: $95,481.00

Co-design of clinical alerts as part of a drug early warning network in Victoria, Australia

Principal Investigator: Dr Monica Barratt, Royal Melbourne Institute of Technology.

Amount Awarded: $95,481.00

Detection of fever via wearable thermometers: An early intervention strategy to reduce the risk of drug-related toxicity at music festivals, a feasibility and acceptability study

Principal Investigator: Prof Andrew Dawson, University of Sydney.

Amount awarded: $95,000.00

Detection of fever via wearable thermometers: An early intervention strategy to reduce the risk of drug-related toxicity at music festivals, a feasibility and acceptability study

Principal Investigator: Prof Andrew Dawson, University of Sydney.

Amount awarded: $95,000.00

BeSMART: feasibility and preliminary efficacy of an intervention for family members impacted by methamphetamine

Principal Investigator: A/Prof Peter Kelly, University of Wollongong

Amount awarded: $61,342.00

BeSMART: feasibility and preliminary efficacy of an intervention for family members impacted by methamphetamine

Principal Investigator: A/Prof Peter Kelly, University of Wollongong

Amount awarded: $61,342.00

Understanding emerging opioid-related harms through improved surveillance, drug checking and information sharing systems.

Principal Investigator: A/Prof Suzanne Nielson, Monash University

Amount awarded: $98,774.00

Understanding emerging opioid-related harms through improved surveillance, drug checking and information sharing systems.

Principal Investigator: A/Prof Suzanne Nielson, Monash University

Amount awarded: $98,774.00

Risk communication for people who use MDMA/‘ecstasy’ and related drugs: establishing guidance on consumer preferences and behavioural responses to drug alerts

Principal Investigator: Dr Amy Peacock, University of New South Wales

Amount awarded: $96,120.00

Risk communication for people who use MDMA/‘ecstasy’ and related drugs: establishing guidance on consumer preferences and behavioural responses to drug alerts

Principal Investigator: Dr Amy Peacock, University of New South Wales

Amount awarded: $96,120.00

Determining the feasibility and efficacy of Goal Management Training for improving treatment retention and outcomes during residential treatment for methamphetamine dependence

Principal Investigator: Prof Antonio Verdejo-Garcia, Monash University

Amount awarded: $94,369.00

Determining the feasibility and efficacy of Goal Management Training for improving treatment retention and outcomes during residential treatment for methamphetamine dependence

Principal Investigator: Prof Antonio Verdejo-Garcia, Monash University

Amount awarded: $94,369.00

Seed Funding Recipients: Round 2

MethAmphetamine use in young people: Sub-anaesthetic ketamine open-label trial; MASKOT

Principal Investigator: Dr Gill Bedi, Orygen: The National Centre of Excellence in Youth Mental Health

Amount awarded: $99,703.53.

MethAmphetamine use in young people: Sub-anaesthetic ketamine open-label trial; MASKOT

Principal Investigator: Dr Gill Bedi, Orygen: The National Centre of Excellence in Youth Mental Health

Amount awarded: $99,703.53.

Methamphetamine and mutual support: a mixed methods exploration of SMART recovery participants’ characteristics and opportunities for enhanced referral pathways.

Principal Investigator: A/Prof Peter Kelly, University of Wollongong

Amount awarded: $77,489.00.

Methamphetamine and mutual support: a mixed methods exploration of SMART recovery participants’ characteristics and opportunities for enhanced referral pathways.

Principal Investigator: A/Prof Peter Kelly, University of Wollongong

Amount awarded: $77,489.00.

A pilot randomised controlled trial (RCT) of personalised approach bias modification for methamphetamine use disorder.

Principal Investigator: A/Prof Victoria Manning, Monash University

Amount awarded: $97,595.30.

A pilot randomised controlled trial (RCT) of personalised approach bias modification for methamphetamine use disorder.

Principal Investigator: A/Prof Victoria Manning, Monash University

Amount awarded: $97,595.30.

Feasibility, consumer acceptability and behavioural outcomes associated with take-home fentanyl test strips.

Principal Investigator: Dr Rachel Sutherland, The University of New South Wales

Amount awarded: $38,795.00.

Feasibility, consumer acceptability and behavioural outcomes associated with take-home fentanyl test strips.

Principal Investigator: Dr Rachel Sutherland, The University of New South Wales

Amount awarded: $38,795.00.

An acceptability and feasibility study of the We Can Do This online therapeutic program in primary care and residential rehabilitation settings.

Principal Investigator: A/Prof James Ward, South Australian Health and Medical Research Institute

Amount awarded: $68,400.00.

An acceptability and feasibility study of the We Can Do This online therapeutic program in primary care and residential rehabilitation settings.

Principal Investigator: A/Prof James Ward, South Australian Health and Medical Research Institute

Amount awarded: $68,400.00.

Seed Funding Recipients: Round 1

Increasing the capacity of a local health district to respond to methamphetamine-related harm: developing an integrated model of care informed by linked data and consumer and clinician views

Principal Investigator: Dr Briony Larance, University of Wollongong

Amount awarded: $66,190.00.

Increasing the capacity of a local health district to respond to methamphetamine-related harm: developing an integrated model of care informed by linked data and consumer and clinician views

Principal Investigator: Dr Briony Larance, University of Wollongong

Amount awarded: $66,190.00.

Sentinel surveillance for emerging illicitly manufactured fentanyl use in an inner-city opioid agonist treatment service

Principal Investigator: Dr Craig Rodgers, St Vincent’s Hospital Sydney

Amount awarded: $29,947.50

Sentinel surveillance for emerging illicitly manufactured fentanyl use in an inner-city opioid agonist treatment service

Principal Investigator: Dr Craig Rodgers, St Vincent’s Hospital Sydney

Amount awarded: $29,947.50

Emerging Drug Network of Australia (EDNA)

Principal Investigator: Dr Jessica Soderstrom, Royal Perth Hospital

Amount awarded: $100,000.00

Emerging Drug Network of Australia (EDNA)

Principal Investigator: Dr Jessica Soderstrom, Royal Perth Hospital

Amount awarded: $100,000.00

Capacity Building grants

The LiMA@RPAH study: a randomised double-blind placebo-controlled study of lisdexamfetamine for the treatment of methamphetamine dependence

Principal Investigator: Prof Paul Haber, Royal Prince Alfred Hospital

Amount awarded: $100,000.00 

The LiMA@RPAH study: a randomised double-blind placebo-controlled study of lisdexamfetamine for the treatment of methamphetamine dependence

Principal Investigator: Prof Paul Haber, Royal Prince Alfred Hospital

Amount awarded: $100,000.00 

Developing a clinical data laboratory for methamphetamine use in NSW: The MAData project

Principal Investigator: Prof Nicholas Lintzeris, South Eastern Sydney Local Health District 

Amount awarded: $104,000.00 

Developing a clinical data laboratory for methamphetamine use in NSW: The MAData project

Principal Investigator: Prof Nicholas Lintzeris, South Eastern Sydney Local Health District 

Amount awarded: $104,000.00 

South Australian drug early warning system – Emergency Department admission blood psychoactive testing

Principal Investigator: Dr Peter Stockham, Forensic Science SA 

Amount awarded: $100,000.00    

South Australian drug early warning system – Emergency Department admission blood psychoactive testing

Principal Investigator: Dr Peter Stockham, Forensic Science SA 

Amount awarded: $100,000.00    

National Centre for Clinical
Research on Emerging Drugs

We would like to acknowledge the traditional owners of this country
and pay our respects to Elders past, present and emerging.

© Copyright 2021